Pancreatic cancer screening

Irina M. Cazacu; Ben S. Singh; Florencia McAllister; Adrian Saftoiu; Manoop S. Bhutani

doi:10.1007/978-3-031-05724-3_4

Pancreatic cancer screening

Irina M. Cazacu, Ben S. Singh, Florencia McAllister, Adrian Saftoiu, Manoop S. Bhutani

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Multiple centers across the world have developed pancreatic cancer (PC) screening programs for high-risk individuals with the aim to detect precursor lesions or PC in an early and potentially curable stage. Even though there is limited data suggesting that screening may improve survival, selective screening of high-risk individuals is considered beneficial. Screening for PC should preferably be performed at major centers with multidisciplinary screening program or in the setting of research protocols. This chapter will review data about risk factors and genetic predisposition for PC, will provide current information on PC precursor lesions, and highlight current screening strategies and preliminary results.

Original language	English (US)
Title of host publication	Pancreatic Cancer
Subtitle of host publication	A Multidisciplinary Approach
Publisher	Springer International Publishing
Pages	39-47
Number of pages	9
ISBN (Electronic)	9783031057243
ISBN (Print)	9783031057236
DOIs	https://doi.org/10.1007/978-3-031-05724-3_4
State	Published - Oct 22 2022

Keywords

EUS
Germline mutations
High-risk individuals
Pancreatic cancer
Screening

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-031-05724-3_4

Cite this

@inbook{f265d1cd1bb341e4b25896c4182df2b4,

title = "Pancreatic cancer screening",

abstract = "Multiple centers across the world have developed pancreatic cancer (PC) screening programs for high-risk individuals with the aim to detect precursor lesions or PC in an early and potentially curable stage. Even though there is limited data suggesting that screening may improve survival, selective screening of high-risk individuals is considered beneficial. Screening for PC should preferably be performed at major centers with multidisciplinary screening program or in the setting of research protocols. This chapter will review data about risk factors and genetic predisposition for PC, will provide current information on PC precursor lesions, and highlight current screening strategies and preliminary results.",

keywords = "EUS, Germline mutations, High-risk individuals, Pancreatic cancer, Screening",

author = "Cazacu, {Irina M.} and Singh, {Ben S.} and Florencia McAllister and Adrian Saftoiu and Bhutani, {Manoop S.}",

year = "2022",

month = oct,

day = "22",

doi = "10.1007/978-3-031-05724-3_4",

language = "English (US)",

isbn = "9783031057236",

pages = "39--47",

booktitle = "Pancreatic Cancer",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Pancreatic cancer screening

AU - Cazacu, Irina M.

AU - Singh, Ben S.

AU - McAllister, Florencia

AU - Saftoiu, Adrian

AU - Bhutani, Manoop S.

PY - 2022/10/22

Y1 - 2022/10/22

N2 - Multiple centers across the world have developed pancreatic cancer (PC) screening programs for high-risk individuals with the aim to detect precursor lesions or PC in an early and potentially curable stage. Even though there is limited data suggesting that screening may improve survival, selective screening of high-risk individuals is considered beneficial. Screening for PC should preferably be performed at major centers with multidisciplinary screening program or in the setting of research protocols. This chapter will review data about risk factors and genetic predisposition for PC, will provide current information on PC precursor lesions, and highlight current screening strategies and preliminary results.

AB - Multiple centers across the world have developed pancreatic cancer (PC) screening programs for high-risk individuals with the aim to detect precursor lesions or PC in an early and potentially curable stage. Even though there is limited data suggesting that screening may improve survival, selective screening of high-risk individuals is considered beneficial. Screening for PC should preferably be performed at major centers with multidisciplinary screening program or in the setting of research protocols. This chapter will review data about risk factors and genetic predisposition for PC, will provide current information on PC precursor lesions, and highlight current screening strategies and preliminary results.

KW - EUS

KW - Germline mutations

KW - High-risk individuals

KW - Pancreatic cancer

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=85153996673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85153996673&partnerID=8YFLogxK

U2 - 10.1007/978-3-031-05724-3_4

DO - 10.1007/978-3-031-05724-3_4

M3 - Chapter

AN - SCOPUS:85153996673

SN - 9783031057236

SP - 39

EP - 47

BT - Pancreatic Cancer

PB - Springer International Publishing

ER -

Pancreatic cancer screening

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this